+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Latamoxef"

Latamoxef Sodium API Market by End Use (Human, Veterinary), Application (Ambulatory Care, General Hospital, Pharmaceutical Industry), Route of Administration, Distribution Channel, Dosage Form - Global Forecast 2025-2030 - Product Thumbnail Image

Latamoxef Sodium API Market by End Use (Human, Veterinary), Application (Ambulatory Care, General Hospital, Pharmaceutical Industry), Route of Administration, Distribution Channel, Dosage Form - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Latamoxef is an antibiotic belonging to the cephalosporin class of drugs. It is used to treat a wide range of bacterial infections, including those of the respiratory tract, skin, and urinary tract. It is also used to treat certain types of meningitis. Latamoxef is available in both oral and intravenous formulations. Latamoxef is widely used in Latin America, where it is one of the most commonly prescribed antibiotics. It is also used in other parts of the world, including Europe and the United States. The drug is generally well tolerated, with few side effects. The Latamoxef market is highly competitive, with several major pharmaceutical companies producing the drug. These include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Generic versions of the drug are also available from a number of manufacturers. Show Less Read more